Estradiol 3-glucuronide
Estradiol 3-glucuronide | |
---|---|
Estradiol 3-glucuronide.svg | |
17β-Hydroxyestra-1,3,5(10)-trien-3-yl β-D-glucopyranosiduronic acid | |
(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-{[(1S,3aS,3bR,9bS,11aS)-1-hydroxy-11a-methyl-2,3,3a,3b,4,5,9b,10,11,11a-decahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}oxane-2-carboxylic acid | |
別称 E2-3G; 17β-Estradiol 3-(β-D-glucuronide) | |
Identifiers | |
15270-30-1 | |
ChEBI | |
ChEMBL | ChEMBL2074591 |
ChemSpider | 389587 |
| |
Jmol-3D images | Image |
KEGG | C05503 |
PubChem | 440713 |
| |
Properties | |
C24H32O8 | |
Molar mass | 448.512 g/mol g·mol−1 |
特記なき場合、データは常温(25 °C)・常圧(100 kPa)におけるものである。 |
Estradiol 3-glucuronide (E2-3G), also known as 17β-estradiol 3-(β-D-glucuronide), is a naturally occurring and endogenous estrogen conjugate.[1] It is specifically the C3 glucuronide conjugate of estradiol, the major estrogen in the body.[1] It is formed from estradiol in the liver by UDP-glucuronosyltransferase via attachment of glucuronic acid and is eventually excreted in urine and bile.[2][3] Similarly to estrogen sulfates like estrone sulfate, estrogen glucuronides have much higher water solubility than do unconjugated estrogens like estradiol.[3]
Estrogen glucuronides can be deconjugated into the corresponding free estrogens by β-glucuronidase in tissues that express this enzyme, such as the mammary gland.[2] As a result, estrogen glucuronides have estrogenic activity via conversion into estrogens.[2]
Estradiol 3-glucuronide is a positional isomer of estradiol 17β-glucuronide.
See also
- Catechol estrogen
- Estradiol sulfate
- Estriol glucuronide
- Estriol sulfate
- Estrogen conjugate
- Lipoidal estradiol
References
- ↑ 以下の位置に戻る: 1.0 1.1 "Human Metabolome Database: Showing metabocard for 17-beta-Estradiol-3-glucuronide (HMDB0006224)".
- ↑ 以下の位置に戻る: 2.0 2.1 2.2 Zhu BT, Conney AH (January 1998). "Functional role of estrogen metabolism in target cells: review and perspectives". Carcinogenesis. 19 (1): 1–27. doi:10.1093/carcin/19.1.1. PMID 9472688.
- ↑ 以下の位置に戻る: 3.0 3.1 Kuhl H (2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration" (PDF). Climacteric. 8 (Suppl 1): 3–63. doi:10.1080/13697130500148875. PMID 16112947. S2CID 24616324.
External links
|
|